SGER: Development of a Novel Approach for the In Situ Analysis of Transcription Factor-DNA Complexes
SGER:开发转录因子-DNA 复合物原位分析新方法
基本信息
- 批准号:9817820
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-10-01 至 2000-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
9817820AriasIt is well established that DNA-binding factors modulate transcription in eukaryotes. It is thus of interest to know how and where these factors interact with promoter DNA. To date, such information has largely been obtained from investigations with protein extracts and nucleosome-free DNA templates. Future advances in our understanding of transcriptional processes will require new tools for evaluating the validity of in vitro results and determining how transcription complexes operate in vivo. The overall goal of this research is to develop a novel method for characterizing in vivo interactions between nuclear transcription factors and their binding sites in cellular promoters. The strategy relies on the ability of formaldehyde to rapidly and efficiently cross-link proteins with their DNA-binding sites in vivo. Fixed chromatin is then isolated mechanically or enzymatically-cleaved into smaller fragments, and immuno-enriched for the covalently-linked protein and DNA complex of interest. Cross-links in complexes are reversible at 65C, thus yielding individual protein and DNA components for Western blot or PCR analysis, respectively. Although untested as yet with living cells, preliminary results with a basic/leucine-zipper transcription factor and plant chromatin in vitro suggest that the proposed methodology is technically feasible. A successful outcome to this work will result in a significant paradigm shift in our ability to probe the molecular mechanisms of gene expression. Important biological questions that may be addressed by this work include: 1) identifying in vivo promoter-binding sites for a transcription factor, 2) isolating new genes that are regulated by a transcription factor, 3) analyzing changes in the DNA-binding activity of a factor at a known promoter site, and 4) identifying which member of a multi-gene family of factors binds to a common target site in vivo.This research is expected to provide new tools for understanding how genes are regulated in cells. As genes underlie fundamental events in an organism's development, homeostasis, and defense, we envision that work here will advance our understanding of how multicellular organisms orchestrate these processes.
9817820 Arias DNA结合因子在真核生物中调节转录已得到充分证实。因此,了解这些因子如何以及在何处与启动子DNA相互作用是有意义的。迄今为止,这些信息主要是从蛋白质提取物和无核小体DNA模板的研究中获得的。我们对转录过程的理解的未来进展将需要新的工具来评估体外结果的有效性,并确定转录复合物如何在体内运作。本研究的总体目标是开发一种新的方法,用于表征核转录因子与细胞启动子中的结合位点之间的体内相互作用。该策略依赖于甲醛在体内快速有效地将蛋白质与其DNA结合位点交联的能力。然后将固定的染色质机械分离或酶切成较小的片段,并对共价连接的蛋白质和感兴趣的DNA复合物进行免疫富集。复合物中的交联在65 ℃下是可逆的,从而分别产生用于Western印迹或PCR分析的单个蛋白质和DNA组分。虽然未经测试的活细胞,初步结果与基本/亮氨酸拉链转录因子和植物染色质在体外表明,所提出的方法在技术上是可行的。这项工作的成功结果将导致我们探测基因表达的分子机制的能力的重大范式转变。这项工作可能解决的重要生物学问题包括:1)鉴定转录因子的体内启动子结合位点,2)分离受转录因子调节的新基因,3)分析已知启动子位点处因子的DNA结合活性的变化,以及4)鉴定多基因因子家族中的哪一个成员与体内的共同靶位点结合。这项研究有望为理解基因在细胞中是如何调控的提供新的工具。由于基因是生物体发育、体内平衡和防御中基本事件的基础,我们设想这里的工作将促进我们对多细胞生物如何协调这些过程的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan Arias其他文献
Generation of nonviral integration-free human iPS cell line KISCOi001-A from normal human fibroblasts, under defined xeno-free and feeder-free conditions.
在规定的无异源和无饲养条件下,从正常人成纤维细胞生成非病毒无整合人 iPS 细胞系 KISCOi001-A。
- DOI:
10.1016/j.scr.2021.102193 - 发表时间:
2021 - 期刊:
- 影响因子:1.2
- 作者:
J. Inzunza;Jonathan Arias;J. Segura;I. Nalvarte;M. Varshney - 通讯作者:
M. Varshney
Generation of a human induced pluripotent stem cell line (PHAi003) from a primary immunodeficient patient with CD70 mutation.
从具有 CD70 突变的原发性免疫缺陷患者中产生人类诱导多能干细胞系 (PHAi003)。
- DOI:
10.1016/j.scr.2019.101612 - 发表时间:
2019 - 期刊:
- 影响因子:1.2
- 作者:
Jonathan Arias;Jingwei Yu;Hassan Abolhassani;Likun Du;Joaquín Custodio;Q. Pan - 通讯作者:
Q. Pan
Using High-Content Screening Technology as a Tool to Generate Single-Cell Patient-Derived Gene-Corrected Isogenic iPS Clones for Parkinson’s Disease Research
使用高内涵筛选技术作为工具生成单细胞患者来源的基因校正的同基因 iPS 克隆,用于帕金森病研究
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Peter A. Barbuti;Paul M. A. Antony;Bruno F. R. Santos;F. Massart;Gérald Cruciani;C. Dording;Jonathan Arias;J. Schwamborn;R. Krüger - 通讯作者:
R. Krüger
A network-based approach to the analysis of ontogenetic diet shifts: An example with an endangered, small-sized fish
- DOI:
10.1016/j.ecocom.2010.11.005 - 发表时间:
2011-03-01 - 期刊:
- 影响因子:
- 作者:
Rodrigo Ramos-Jiliberto;Fernanda S. Valdovinos;Jonathan Arias;Carles Alcaraz;Emili García-Berthou - 通讯作者:
Emili García-Berthou
Outcomes After Minimally Invasive Sacroiliac Joint Fusion: A Scoping Review
- DOI:
10.1016/j.wneu.2022.09.094 - 发表时间:
2022-12-01 - 期刊:
- 影响因子:
- 作者:
Yusuf Mehkri;Abtahi Tishad;Spencer Nichols;Kyle W. Scott;Jonathan Arias;Brandon Lucke-Wold;Gazanfar Rahmathulla - 通讯作者:
Gazanfar Rahmathulla
Jonathan Arias的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan Arias', 18)}}的其他基金
Stimulus-reversible Co-repression in Regulation of a Plant bZIP Factor
植物 bZIP 因子调节中的刺激可逆共抑制
- 批准号:
0346065 - 财政年份:2003
- 资助金额:
-- - 项目类别:
Continuing Grant
Arabidopsis2010: Determining Genome-wide Transcription Networks of TGA Factors
拟南芥2010:确定 TGA 因子的全基因组转录网络
- 批准号:
0209697 - 财政年份:2002
- 资助金额:
-- - 项目类别:
Continuing Grant
Stimulus-reversible Co-repression in Regulation of a Plant bZIP Factor
植物 bZIP 因子调节中的刺激可逆共抑制
- 批准号:
0091927 - 财政年份:2001
- 资助金额:
-- - 项目类别:
Continuing Grant
Biochemistry of Signal-Responsive Transcription in Plants
植物信号响应转录的生物化学
- 批准号:
9728789 - 财政年份:1998
- 资助金额:
-- - 项目类别:
Standard Grant
Signal-Responsive Transcription of Plant Nuclear Genes
植物核基因的信号响应转录
- 批准号:
9527364 - 财政年份:1996
- 资助金额:
-- - 项目类别:
Standard Grant
Minority Postdoctoral Research Fellowship
少数族裔博士后研究奖学金
- 批准号:
9006142 - 财政年份:1990
- 资助金额:
-- - 项目类别:
Fellowship Award
相似国自然基金
水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
- 批准号:32070202
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
- 批准号:
- 批准年份:2020
- 资助金额:40 万元
- 项目类别:
相似海外基金
SBIR Phase II: Development of a Novel Measurement Technology to Enable Longitudinal Multiomic Investigations of the Gut Microbiome
SBIR 第二阶段:开发新型测量技术以实现肠道微生物组的纵向多组学研究
- 批准号:
2314685 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Cooperative Agreement
Development of a novel cancer immunotherapy model targeting human macrophages
开发针对人类巨噬细胞的新型癌症免疫治疗模型
- 批准号:
24K18516 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of a Novel EMG-Based Neural Interface for Control of Transradial Prostheses with Gripping Assistance
开发一种新型的基于肌电图的神经接口,用于通过抓取辅助控制经桡动脉假体
- 批准号:
10748341 - 财政年份:2024
- 资助金额:
-- - 项目类别:
FMO/ML-Guided Drug Design: Accelerating Novel Inhibitor Development and Drug Discovery
FMO/ML 引导的药物设计:加速新型抑制剂的开发和药物发现
- 批准号:
24K20888 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Presymptom: development of a novel machine-learning-derived diagnostic test to rule out infection to enable enhanced clinical care and better targeted anti-microbial use
症状前:开发一种新型的机器学习诊断测试来排除感染,从而加强临床护理和更有针对性的抗菌药物使用
- 批准号:
10089281 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Investment Accelerator
Analysis and quality control of novel mixed cell population for therapeutic development
用于治疗开发的新型混合细胞群的分析和质量控制
- 批准号:
10089851 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Collaborative R&D
Development of novel acyclic chelators for gallium-68 and scandium-44 radiometals used in PET
开发用于 PET 的镓 68 和钪 44 放射性金属的新型无环螯合剂
- 批准号:
EP/V028073/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Application of the virus-like particle (VLP) technology in the development of anti-tick vaccine, utilizing novel salivary proteins from Haemaphysalis longicornis ticks.
利用长角血蜱的新型唾液蛋白,应用病毒样颗粒(VLP)技术开发抗蜱疫苗。
- 批准号:
24K18027 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel 'extended labour induction' balloon to improve safety of labour induction: Prototype development and preliminary clinical study
新型“延长引产”球囊可提高引产安全性:原型开发和初步临床研究
- 批准号:
MR/Y503423/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Establishing the roles of oestrogen receptor 1 (ESR1) in olfactory development and function using novel CRISPR/Cas9-based knockouts in the zebrafish
使用基于 CRISPR/Cas9 的新型斑马鱼基因敲除技术确定雌激素受体 1 (ESR1) 在嗅觉发育和功能中的作用
- 批准号:
BB/Y00003X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant